New drug trial offers hope for ovarian cancer that stopped responding to standard chemo
Disease control
Recruiting now
This study is testing an experimental drug called CBX-12 for women whose ovarian cancer has stopped responding to platinum-based chemotherapy. It aims to see if the drug is safe and can shrink tumors. About 40 participants will receive one of two different doses every three weeks…
Phase: PHASE2 • Sponsor: Cybrexa Therapeutics • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC